Reagent kit "Nutrient medium for the isolation of enterobacteriaceae dry (agar Endo)" according to TU 9385-022-14237183-07
Russia·231070·JSC "NPO "Microgen"·Registered December 08, 2021·N/A- Device Name (English)
- Reagent kit "Nutrient medium for the isolation of enterobacteriaceae dry (agar Endo)" according to TU 9385-022-14237183-07
- Device Name (Russian)
- Набор реагентов "Питательная среда для выделения энтеробактерий сухая (агар Эндо)" по ТУ 9385-022-14237183-07
- Device Type (English)
- N/A
- Device Type (Russian)
- 231070
- Risk Class
- N/A
- OKPD Code
- 20.59.52.140
- Registry Key
- 58365.0
- Registration Number
- ФСР 2007/00353
- Registration Date
- December 08, 2021
- Manufacturer Name (English)
- JSC "NPO "Microgen"
- Manufacturer Name (Russian)
- АО "НПО "Микроген"
- Country (English)
- Russia
- Country (Russian)
- Россия
- Legal Address (English)
- Branch of JSC "NPO "Microgen" in Makhachkala "NPO "Nutrient Media", Russia, 367915, Republic of Dagestan, Makhachkala, Novy Kyakhulai, Decorative Street, 89, bldg. 1
- Legal Address (Russian)
- Филиал АО "НПО "Микроген" в г. Махачкала "НПО "Питательные среды", Россия, 367915, Республика Дагестан, г. Махачкала, п. Новый Кяхулай, ул. Декоративная, д. 89, стр. 1
- Manufacturing Address
- 127473, Россия, Москва, 2-й Волконский пер., д. 10
Access comprehensive regulatory information for Reagent kit "Nutrient medium for the isolation of enterobacteriaceae dry (agar Endo)" according to TU 9385-022-14237183-07 in the Russia medical device market through Pure Global AI's free database. This medical device is registered under Roszdravnadzor registration number ФСР 2007/00353 and manufactured by JSC "NPO "Microgen". The device was registered on December 08, 2021.
This page provides complete registration details including device type, manufacturer information, country of origin (Russia), and regulatory compliance data from the official Russia Roszdravnadzor medical device database. Pure Global AI offers free access to Russia's complete medical device registry, helping global MedTech companies navigate Roszdravnadzor regulations efficiently.